FGF10 Triggers De Novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells.


Journal

Stem cells (Dayton, Ohio)
ISSN: 1549-4918
Titre abrégé: Stem Cells
Pays: England
ID NLM: 9304532

Informations de publication

Date de publication:
22 06 2022
Historique:
received: 28 01 2022
accepted: 23 03 2022
pubmed: 20 4 2022
medline: 25 6 2022
entrez: 19 4 2022
Statut: ppublish

Résumé

Bronchopulmonary dysplasia (BPD) is a neonatal lung disease developing in premature babies characterized by arrested alveologenesis and associated with decreased Fibroblast growth factor 10 (FGF10) expression. One-week hyperoxia (HYX) exposure of newborn mice leads to a permanent arrest in alveologenesis. To test the role of Fgf10 signaling to promote de novo alveologenesis following hyperoxia, we used transgenic mice allowing inducible expression of Fgf10 and recombinant FGF10 (rFGF10) protein delivered intraperitoneally. We carried out morphometry analysis, and IF on day 45. Alveolospheres assays were performed co-culturing AT2s from normoxia (NOX) with FACS-isolated Sca1Pos resident mesenchymal cells (rMC) from animals exposed to NOX, HYX-PBS, or HYX-FGF10. scRNAseq between rMC-Sca1Pos isolated from NOX and HYX-PBS was also carried out. Transgenic overexpression of Fgf10 and rFGF10 administration rescued the alveologenesis defects following HYX. Alveolosphere assays indicate that the activity of rMC-Sca1Pos is negatively impacted by HYX and partially rescued by rFGF10 treatment. Analysis by IF demonstrates a significant impact of rFGF10 on the activity of resident mesenchymal cells. scRNAseq results identified clusters expressing Fgf10, Fgf7, Pdgfra, and Axin2, which could represent the rMC niche cells for the AT2 stem cells. In conclusion, we demonstrate that rFGF10 administration is able to induce de novo alveologenesis in a BPD mouse model and identified subpopulations of rMC-Sca1Pos niche cells potentially representing its cellular target.

Identifiants

pubmed: 35437594
pii: 6567429
doi: 10.1093/stmcls/sxac025
pmc: PMC9216486
doi:

Substances chimiques

FGF10 protein, human 0
Fgf10 protein, mouse 0
Fibroblast Growth Factor 10 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-617

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

Front Cell Dev Biol. 2021 Jun 15;9:662059
pubmed: 34211971
Int J Biol Sci. 2012;8(9):1281-90
pubmed: 23136556
Cell Stem Cell. 2020 Sep 3;27(3):366-382.e7
pubmed: 32750316
Stem Cells. 2021 Oct;39(10):1382-1394
pubmed: 34048616
Genome Biol. 2018 Feb 6;19(1):15
pubmed: 29409532
Proc Natl Acad Sci U S A. 2016 Dec 13;113(50):E8151-E8158
pubmed: 27911817
Cancer Res Treat. 2006;38(3):144-51
pubmed: 19771275
Am J Physiol Lung Cell Mol Physiol. 2018 Nov 1;315(5):L858-L869
pubmed: 30113228
Children (Basel). 2021 Apr 13;8(4):
pubmed: 33924638
Am J Physiol Gastrointest Liver Physiol. 2015 Apr 15;308(8):G678-90
pubmed: 25721301
Development. 2013 Sep;140(18):3731-42
pubmed: 23924632
Mol Cell Biol. 1993 Feb;13(2):841-51
pubmed: 8423806
Development. 1997 Dec;124(23):4867-78
pubmed: 9428423
Am J Respir Crit Care Med. 2009 Sep 1;180(5):424-36
pubmed: 19498056
Am J Physiol Lung Cell Mol Physiol. 2007 Feb;292(2):L550-8
pubmed: 17071719
J Perinatol. 2006 Oct;26(10):640-4
pubmed: 17006525
Nature. 2020 Nov;587(7835):619-625
pubmed: 33208946
Development. 2015 Dec 1;142(23):4139-50
pubmed: 26511927
Front Cell Dev Biol. 2021 May 13;9:671841
pubmed: 34055804
J Clin Invest. 2011 Nov;121(11):4409-19
pubmed: 21985786
Cell Rep. 2020 Dec 22;33(12):108549
pubmed: 33357434
Stem Cell Res. 2013 Nov;11(3):1222-33
pubmed: 24029687
Am J Respir Cell Mol Biol. 2014 Oct;51(4):474-84
pubmed: 24932885
Hum Mol Genet. 2019 May 1;28(9):1429-1444
pubmed: 30566624
J Biol Chem. 2013 May 24;288(21):15318-25
pubmed: 23558680
Stem Cells. 2022 May 27;40(5):479-492
pubmed: 35445270
Am J Physiol Lung Cell Mol Physiol. 2015 May 15;308(10):L1014-24
pubmed: 25820524
Dev Cell. 2017 Oct 9;43(1):48-59.e5
pubmed: 29017029
J Pathol. 2016 Jun;239(2):152-61
pubmed: 26924464
Front Genet. 2019 Jan 23;9:746
pubmed: 30728831
J Med Genet. 2011 Oct;48(10):705-9
pubmed: 21742743
Cell. 2017 Sep 7;170(6):1134-1148.e10
pubmed: 28886382
Sci Rep. 2019 Mar 26;9(1):5233
pubmed: 30914743
Cells. 2020 May 21;9(5):
pubmed: 32455591
Biochem Biophys Res Commun. 2012 Jun 22;423(1):134-9
pubmed: 22634316
Genes Immun. 2010 Jun;11(4):319-25
pubmed: 19798075
Front Med (Lausanne). 2015 Apr 28;2:27
pubmed: 25973420
Nat Commun. 2021 Mar 10;12(1):1565
pubmed: 33692365
Stem Cells. 2009 Mar;27(3):623-33
pubmed: 19074419
Respir Med. 2017 Nov;132:170-177
pubmed: 29229093
Front Genet. 2019 Mar 14;10:178
pubmed: 30923534

Auteurs

Sara Taghizadeh (S)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Cho-Ming Chao (CM)

University Children's Hospital, University Medical Center Rostock, Rostock, Germany.
Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Stefan Guenther (S)

MPI Lung and Heart, Bad Nauheim, Germany.

Lea Glaser (L)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Luisa Gersmann (L)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Gabriela Michel (G)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Simone Kraut (S)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Kerstin Goth (K)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Janine Koepke (J)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Monika Heiner (M)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Ana Ivonne Vazquez-Armendariz (AI)

Institute for Lung Health (ILH), Giessen, Germany.

Susanne Herold (S)

Institute for Lung Health (ILH), Germany.

Christos Samakovlis (C)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Norbert Weissmann (N)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Francesca Ricci (F)

Neonatology and Pulmonary Rare Disease Unit, Chiesi Farmaceutici S.p.A., Parma, Italy.

Giorgio Aquila (G)

Neonatology and Pulmonary Rare Disease Unit, Chiesi Farmaceutici S.p.A., Parma, Italy.

Laurent Boyer (L)

Univ Paris Est Creteil, INSERM, IMRB, Creteil, France.

Harald Ehrhardt (H)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Parviz Minoo (P)

University of Southern California, Los Angeles, CA, USA.

Saverio Bellusci (S)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Stefano Rivetti (S)

Cardio-Pulmonary Institute (CPI) and Department of Pulmonary and Critical Care Medicine and Infectious Diseases, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Justus Liebig University Giessen, Giessen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH